Piper methysticum root clinical trials
Also written Kava.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How each study uses piper methysticum root is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2015 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 7
Masonic Cancer Center, University of Minnesota (2) · University of Florida (2) · Thorne HealthTech, Inc (1) · University of Melbourne (1) · National Institutes of Health Clinical Center (CC) (1) · National Center for Complementary and Integrative Health (NCCIH) (1)
Often tested with
Tested in the same studies.
Piper methysticum (2)
Studies
Open first, then newest update. How each study uses piper methysticum root is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Effect of Kava on Anxiety and Stress in Cancer SurvivorsWithdrawnEarly Phase 1Masonic Cancer Center, University of MinnesotaNCT06213298Written as KavaHow we know
- Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free KavaTerminatedPhase 2University of FloridaNCT05081882Written as KavaHow we know
- Kavalactones on Sleep and Cortisol in Healthy Special Forces TraineesCompletedNot applicableThorne HealthTech, IncNCT05381025Written as Kava (Piper methysticum) extractHow we know
- Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNKWithdrawnPhase 1University of FloridaNCT03606655Written as KavaHow we know
- Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled TrialCompletedPhase 4University of MelbourneNCT02219880Written as Kava (240mg of kavalactones per day)How we know
- Investigation of Kava Effects on NNK MetabolismCompletedNot applicableMasonic Cancer Center, University of MinnesotaNCT02500472Written as KavaHow we know
- Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)TerminatedPhase 2National Center for Complementary and Integrative Health (NCCIH)NCT00083980Written as KavaHow we know
- Effects of Kava on the Body's Elimination of Caffeine and DextromethorphanCompletedPhase 4National Institutes of Health Clinical Center (CC)NCT00009542Written as kava (Piper methysticum)How we know
Codes
What other systems call piper methysticum root · ClinicalTrials.gg INT016125
- RxNorm 259421One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 259421 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.